---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-027266"
form_type: "8-K"
ticker: "LPCN"
cik: "0001535955"
company_name: "Lipocine Inc."
filed_at: "2026-06-04T20:05:28+00:00"
generated_at: "2026-06-04T20:18:18.653357+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Shareholders approve Lipocine stock plan amendment; authorized shares raised to 1M

## Summary
- Shareholders approved Sixth Amended and Restated 2014 Stock Plan on June 3, 2026.
- Plan increases individual award limit from 25,000 to 100,000 shares.
- Authorized shares increased by 400,000, from 600,000 to 1,000,000 shares.
- Four directors elected to one-year terms: Dr. Mahesh V. Patel, John W. Higuchi, Dr. Jill M. Jene, Dr. Richard Dana Ono.
- Ratification of Tanner LLC as independent auditor for FY 2026 and advisory vote on executive compensation both approved.

## SEC filing metadata
- accession: 0001493152-26-027266
- form_type: 8-K
- ticker: LPCN
- cik: 0001535955
- company_name: Lipocine Inc.
- filed_at: 2026-06-04T20:05:28+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1535955/000149315226027266/0001493152-26-027266-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1535955/000149315226027266/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-027266
- JSON: https://secwatch.observer/filing/0001493152-26-027266.json
- Plain text: https://secwatch.observer/filing/0001493152-26-027266.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.